Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia
Not available.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ferrata Storti Foundation
2026-03-01
|
| Collection: | Haematologica |
| Accès en ligne: | https://haematologica.org/article/view/13422 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
